GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Net Margin %

Notable Labs (Notable Labs) Net Margin % : -3,633.55% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Notable Labs's Net Income for the six months ended in Dec. 2023 was $-11.26 Mil. Notable Labs's Revenue for the six months ended in Dec. 2023 was $0.31 Mil. Therefore, Notable Labs's net margin for the quarter that ended in Dec. 2023 was -3,633.55%.

The historical rank and industry rank for Notable Labs's Net Margin % or its related term are showing as below:

NTBL' s Net Margin % Range Over the Past 10 Years
Min: -180087.5   Med: -5632.28   Max: -3633.55
Current: -3633.55


NTBL's Net Margin % is ranked worse than
84.61% of 1033 companies
in the Biotechnology industry
Industry Median: -156.83 vs NTBL: -3633.55

Notable Labs Net Margin % Historical Data

The historical data trend for Notable Labs's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Net Margin % Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Net Margin %
-5,632.28 -180,087.50 -3,633.55

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Net Margin % -5,632.28 -180,087.50 -3,633.55

Competitive Comparison of Notable Labs's Net Margin %

For the Biotechnology subindustry, Notable Labs's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Notable Labs's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's Net Margin % distribution charts can be found below:

* The bar in red indicates where Notable Labs's Net Margin % falls into.



Notable Labs Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Notable Labs's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-11.264/0.31
=-3,633.55 %

Notable Labs's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-11.264/0.31
=-3,633.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Notable Labs  (NAS:NTBL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Notable Labs Net Margin % Related Terms

Thank you for viewing the detailed overview of Notable Labs's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.